Form 4: Cardlytics CFO's Routine Stock Sale for Tax Obligations

Cardlytics' Chief Financial Officer, Alexis DeSieno, sold shares to cover tax obligations following the vesting of restricted stock units.

Summary

• Cardlytics CFO Alexis DeSieno acquired 14,349 shares of common stock on January 1, 2026, through the vesting of Restricted Stock Units (RSUs).
• On January 5, 2026, DeSieno sold 8,607 shares of common stock at a weighted average price of $1.17 per share.
• The sale was exclusively to satisfy tax withholding obligations related to the RSU vesting.
• Following these transactions, DeSieno beneficially owns 201,159 shares of common stock directly.
• An additional 14,350 Restricted Stock Units remain beneficially owned.

Sentiment

Score: 5

Explanation: A routine Form 4 filing reporting RSU vesting and a subsequent tax-related share sale. This is a neutral event, reflecting standard executive compensation practices rather than a significant positive or negative operational or financial development.

Positives

• The vesting of 14,349 Restricted Stock Units indicates continued employment and performance of the Chief Financial Officer.
• The sale of shares was solely for tax withholding obligations, not a discretionary sale to reduce exposure.

Negatives

• The Chief Financial Officer's direct beneficial ownership of common stock decreased by 8,607 shares due to the tax-related sale.

Future Outlook

NA

Industry Context

This is a routine insider transaction filing (Form 4) for a Chief Financial Officer, common across all industries for executives receiving equity compensation. It does not provide specific insights into Cardlytics' industry trends or competitive landscape.

Comparison to Industry Standards

• This is a standard Form 4 filing reporting an insider transaction. The vesting of RSUs and subsequent sale for tax purposes is a common practice for executives receiving equity compensation across publicly traded companies.
• There are no specific comparable companies or projects mentioned in the filing to assess against.

Stakeholder Impact

• Shareholders: Minor dilution from RSU vesting, but the subsequent tax sale is a common practice. The overall impact on share price from this routine transaction is typically minimal.
• Employees: The RSU vesting schedule highlights the company's equity compensation structure for executives, which can be a positive for employee retention and motivation.

Next Steps

• Remaining RSU installments are scheduled to vest on April 1, 2026, provided continued employment.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations. Such transactions are common for executives and do not typically indicate a change in the company's fundamental performance or outlook. Therefore, it provides no new information that would warrant a change in investment recommendation.

Keywords

Cardlytics, CDLX, Form 4, Insider Trading, Restricted Stock Units, RSU, Stock Vesting, Tax Withholding, Alexis DeSieno, Chief Financial Officer